tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
AstraZeneca’s Anselamimab Trial Shows Mixed Results
PremiumCompany AnnouncementsAstraZeneca’s Anselamimab Trial Shows Mixed Results
2M ago
Fortress Biotech’s Subsidiary Merges with Sun Pharma
Premium
Company Announcements
Fortress Biotech’s Subsidiary Merges with Sun Pharma
4M ago
Fortress Biotech Reports Q1 2025 Financial Highlights
Premium
Company Announcements
Fortress Biotech Reports Q1 2025 Financial Highlights
4M ago
Fortress Biotech Inc (FBIO) Q4 Earnings Cheat Sheet
PremiumPre-EarningsFortress Biotech Inc (FBIO) Q4 Earnings Cheat Sheet
6M ago
Fortress Biotech, Partex enter collaboration for asset identification
Premium
The Fly
Fortress Biotech, Partex enter collaboration for asset identification
6M ago
Fortress Biotech, Partex enter collaboration for asset identification, evaluatio
Premium
The Fly
Fortress Biotech, Partex enter collaboration for asset identification, evaluatio
6M ago
Fortress Biotech announces first patient dosed in Phase 2 trial of Triplex
PremiumThe FlyFortress Biotech announces first patient dosed in Phase 2 trial of Triplex
8M ago
Fortress, Cyprium announce FDA acceptance, priority review of NDA for CUTX-101
Premium
The Fly
Fortress, Cyprium announce FDA acceptance, priority review of NDA for CUTX-101
9M ago
Sentynl Therapeutics announces FDA accepts NDA for CUTX-101
Premium
The Fly
Sentynl Therapeutics announces FDA accepts NDA for CUTX-101
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100